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Abstract 15 
CRISPR-Cas technologies have provided programmable gene editing tools that have 16 
revolutionized research. The leading CRISPR-Cas9 and Cas12a enzymes are ideal for 17 
programmed genetic manipulation, however, they are limited for genome-scale interventions. 18 
Here, we utilized a Cas3-based system featuring a processive nuclease, expressed 19 
endogenously or heterologously, for genome engineering purposes. Using an optimized and 20 
minimal CRISPR-Cas3 system (Type I-C) programmed with a single crRNA, large deletions 21 
ranging from 7 - 424 kb were generated in Pseudomonas aeruginosa with high efficiency and 22 
speed. By comparison, Cas9 yielded small deletions and point mutations. Cas3-generated 23 
deletion boundaries were variable in the absence of a homology-directed repair (HDR) template, 24 
and successfully and efficiently specified when present. The minimal Cas3 system is also 25 
portable; large deletions were induced with high efficiency in Pseudomonas syringae and 26 
Escherichia coli using an “all-in-one” vector. Notably, Cas3 generated bi-directional deletions 27 
originating from the programmed cut site, which was exploited to iteratively reduce a P. 28 
aeruginosa genome by 837 kb (13.5%) using 10 distinct crRNAs. We also demonstrate the utility 29 
of endogenous Cas3 systems (Type I-C and I-F) and develop an “anti-anti-CRISPR” strategy to 30 
circumvent endogenous CRISPR-Cas inhibitor proteins. CRISPR-Cas3 could facilitate rapid 31 
strain manipulation for synthetic biological and metabolic engineering purposes, genome 32 
minimization, and the analysis of large regions of unknown function. 33 
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Introduction 35 
CRISPR-Cas systems are a diverse group of RNA-guided nucleases1 that defend prokaryotes 36 
against viral invaders2,3. Due to their relatively simple architecture, gene-editing applications have 37 
focused on Class 2 CRISPR systems4 (i.e. Cas9 and Cas12a), but Class 1 systems hold great 38 
potential for gene editing technologies, despite being more complex5–7. The signature gene in 39 
Class 1 Type I systems is Cas3, a 3’-5’ ssDNA helicase-nuclease enzyme that, unlike Cas9 or 40 
Cas12a, degrades target DNA processively5,6,8–13. This property of CRISPR-Cas3 systems raises 41 
the possibility of its development as a tool for large genomic deletions. 42 
 43 
Organisms from all domains of life contain vast segments of DNA that are poorly characterized, 44 
of unknown function, or may be detrimental for fitness. In prokaryotes, these include prophages, 45 
plasmids, and mobile islands, while in eukaryotes, large regions of repetitive sequences and non-46 
coding DNA are poorly characterized. Methods for generating programmable and rapid large 47 
genomic deletions are needed for the study and engineering of these regions, however these are 48 
currently inefficient14. A methodology that allows for targeted large genomic deletions in any host, 49 
either with precisely programmed or random boundaries, would be broadly useful15.  50 
 51 
Type I systems are the most prevalent CRISPR-Cas systems in nature1, which has enabled the 52 
use of endogenous CRISPR-Cas3 systems for genetic manipulation via self-targeting. This has 53 
been accomplished in Pectobacterium atrosepticum (Type I-F)16, Sulfolobus islandicus (Type I-54 
A)17, in various Clostridium species (Type I-B)18–20, and in Lactobacillus crispatus (Type I-E)21, 55 
leading to deletions as large as 97 kb amongst the self-targeted survivor cells16. Additionally, two 56 
recent studies have repurposed Type I systems for use in human cells, including the 57 
ribonucleoprotein (RNP) based delivery of a Type I-E system22, and the use of I-E and I-B systems 58 
for transcriptional modulation23. Here, we repurposed a Type I-C CRISPR system from 59 
Pseudomonas aeruginosa for genome engineering in microbes. Importantly, by targeting the 60 
genome with a single crRNA and selecting only for survival after editing, this tool is a counter-61 
selection-free approach to programmable genome editing. CRISPR-Cas3 is capable of efficient 62 
genome-scale modifications currently not achievable using other methodologies. It has the 63 
potential to serve as a powerful tool for basic research, discovery, and strain optimization. 64 
 65 
Results 66 
Implementation and optimization of genome editing with CRISPR-Cas3 67 
Type I-C CRISPR-Cas systems utilize just three cas genes to produce the crRNA-guided 68 
Cascade surveillance complex that can recruit Cas3: cas5, cas8, and cas7 (Figure 1A), making it 69 
a minimal system24,25. A previously constructed Pseudomonas aeruginosa PAO1 strain (PAO1IC) 70 
with inducible cas genes and crRNAs26 was used here to conduct targeted genome manipulation. 71 
The expression of a crRNA targeting the genome caused a transient growth delay (Figure 1B), 72 
but survivors were isolated after extended growth. By targeting phzM, a gene required for 73 
production of a blue-green pigment (pyocyanin), we observed yellow cultures (Figure 1C) for 16 74 
out of 36 (44%) biological replicates (18 recovered isolates from two independent phzM targeting 75 
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crRNAs). PCR of genomic DNA confirmed that the yellow cultures had lost this region, while blue-76 
green survivors maintained it (Supplementary Figure 1). Three of these PAO1IC deletion strains 77 
were sequenced, revealing deletions of  23.5 kb, 52.8 kb, and 60.1 kb, and each one was bi-78 
directional relative to the crRNA target site (Figure 1D). This demonstrated the potential for Type 79 
I-C Cas3 systems to be used to induce large genomic deletions with random boundaries 80 
surrounding a programmed target site.  81 
To determine the in vivo processivity of the Cas3 enzyme, we targeted 2 of the 16 extended non-82 
essential (XNES) regions >100 kb in length (Supplementary Table 1) identified from a transposon 83 
sequencing (TnSeq) data set27. The frequency of deletions generated by crRNAs targeting XNES 84 
1 and XNES 2 (along with additional targeting of phzM, which is found in XNES 15) was quantified 85 
revealing that 20-40 % of the surviving colonies had deletions (Figure 2A). To understand how 86 
cells lacking large deletions had survived self-targeting, three possibilities were considered: i) a 87 
cas gene mutation, ii) a PAM or protospacer mutation, or iii) a mutation to the plasmid expressing 88 
the crRNA. Three non-deletion survivors from each of the six self-targeting crRNAs had functional 89 
cas genes when the self-targeting crRNA was replaced with a phage targeting crRNA 90 
(Supplementary Figure 2A), and target sequencing revealed no mutations. PCR-amplification and 91 
sequencing of the crRNA-expressing plasmids isolated from the survivors revealed the primary 92 
escape mechanism: recombination between the direct repeats, leading to the loss of the spacer 93 
(Supplementary Figure 2B). The resulting bands from an additional 17 survivors that lacked 94 
deletions were also ~60 bp shorter (Supplementary Figure 2C), consistent with the loss of one 95 
repeat and spacer.  96 
Spacer excision was successfully prevented by engineering a modified repeat (MR), with six 97 
mutated nucleotides in the stem and three in the loop of the second repeat (Figure 2B), disrupting 98 
homology between the two direct repeats. A phage-targeting crRNA with this new design targeted 99 
phage as well or better than the same crRNA with unmodified repeats (Supplementary Figure 100 
3A). Using the same self-targeting spacers designed against phzM, XNES 1, and XNES 2 with 101 
the MR resulted in a robust increase in editing efficiencies to 94-100% for the six tested crRNAs 102 
(Figure 2A) and spacer excision was no longer detected. 211 of 216 (98 %) total survivor cells 103 
had large deletions based on PCR screening (i.e. > 1 kb), while the remaining 5 had inactive 104 
CRISPR-Cas systems when tested with the phage-targeting crRNA (Supplementary Figure 3B).  105 
The processivity of Cas3 could likely lead to unintended deletions of neighboring essential genes, 106 
if targeting is initiated nearby. To assess the phenotype of such an event, we intentionally targeted 107 
an essential gene, rplQ (a 50S ribosomal subunit protein28). Two different MR crRNAs targeting 108 
rplQ led to a severely extended lag time compared to non-essential gene targeting. Only 8 out of 109 
36 rplQ-targeting biological replicates grew after 24 hours, compared to the transient growth delay 110 
of ~12 hours when targeting non-essential genes (Supplementary Figure 4A). Subsequent 111 
analysis of these 8 survivor cultures with phage targeting assays revealed non-functional cas 112 
genes (Supplementary Figure 4B). Importantly, no spacer excision events were detected in this 113 
experiment or among the 216 replicates screened above. This experiment highlights the 114 
robustness of the deletion method, as the outcome of essential gene versus non-essential gene 115 
targeting is noticeably distinct. 116 
Comparison of Cas3 and Cas9 based editing  117 
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To determine whether large deletions are a direct consequence of the Cas3 enzyme, we 118 
compared self-targeting outcomes to an isogenic strain expressing the non-processive 119 
Streptococcus pyogenes Cas9, PAO1IIA. Two crRNAs (as sgRNAs) that partially overlapped with 120 
the crRNAs used for PAO1IC were targeted to phzM (Figure 2E, Supplementary Figure 5). PCR 121 
and sequencing analysis of these surviving cells revealed that deletions larger than 1 kb are a 122 
rare occurrence (5.6 % assayed survivor cells, n = 72) compared to 98.6 % with PAO1IC (Figure 123 
2E). The more common modes of survival were small deletions between 0.2 – 0.5 kb in length 124 
(19.4 % of all survivors), or 1-3 bp protospacer/PAM deletions/mutations (25 %). Whole-genome 125 
sequencing (WGS) of two large deletion survivors selected for by Cas9 showed lesions of 5 kb 126 
and 23 kb around the target site, respectively. The frequent isolation of small deletions from 127 
targeting with the non-processive SpyCas9 directly implicates Cas3’s enzymatic activity as the 128 
cause of large deletions. 129 
The direct relationship between Cas3 nuclease-helicase activity and survival via large deletions 130 
led us to hypothesize that its processive ssDNA nuclease activity may promote recombination. 131 
To test this, we provided a repair template with ~500 bp of the upstream and downstream regions 132 
flanking the desired deletion to enable homology directed repair (HDR). We chose 0.17 kb and 133 
56.5 kb deletions around phzM and a 249 kb deletion within XNES8 for the programmed deletions 134 
(Supplementary Figure 6). The recombination efficiencies were significantly higher with Cas3 than 135 
with Cas9 (Figure 2F). The 249 kb deletion was incorporated in 22 % of the Cas3-generated 136 
survivors, compared to 0% using Cas9 (2 (1, N = 72) = 9, p = 2.7E-03). The 56.5 kb deletion had 137 
an efficiency of 61 % vs. 5.5 % (2 (1, N = 72) = 25, p = 5.73E-07), and the 0.17 kb deletion had 138 
an efficiency of 100 % vs. 39 % when targeting with Cas3 or Cas9, respectively (2 (1, N = 72) = 139 
31.68, p = 1.82E-08). These data support the hypothesis that Cas3 enhances recombination at 140 
cleavage sites. 141 
Rapid genome minimization of P. aeruginosa using CRISPR-Cas3 editing 142 
Large deletions with undefined boundaries provide an unbiased mechanism for genome 143 
streamlining, screening, and functional genomics. To demonstrate the potential for Cas3, we 144 
aimed to minimize the genome of P. aeruginosa through a series of iterative deletions of the XNES 145 
regions (Figure 3A). Six XNES regions (including XNES 15, carrying phzM) were iteratively 146 
targeted in six parallel lineages (Figure 3B), resulting in 35 independent deletions (WGS revealed 147 
no deletion at XNES 2 in one of the strains). Deletion efficiency remained high (> 80 %) throughout 148 
each round of self-targeting (Supplementary Figure 7). WGS of these 6 multiple deletion strains 149 
(∆61 - ∆66) revealed that no two deletions had the exact same coordinates, highlighting the 150 
stochastic nature of the process. The smallest isolated deletion was 7 kb and the largest 424 kb 151 
(mean: 92.9 kb, median: 58.2 kb). Of note, 4 genes (PA0123, PA1969, PA2024, and PA2156) 152 
previously identified as essential27 were deleted in at least one of the lineages. Most deletions 153 
appeared to be resolved by flanking microhomology regions (Supplementary Table 2), implicating 154 
alternative-end joining29 as the dominant repair process. 155 
To minimize the genome further, one of the already reduced strains was subjected to 4 additional 156 
rounds of deletions at XNES regions for a total of 10 genomic deletions (∆10, Figure 3B). Whole-157 
genome sequencing of the ∆10 strain showed a genome reduction of 849 kb (13.55 % of the 158 
genome). Generation of large deletions resulted in a growth defect in some cases, with 159 
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significantly slower growth in 3 of the 6 deletions strains (∆61, ∆63, and ∆64), with the other 3 160 
growing normally (Figure 3C). ∆10 also displayed a decrease in fitness, showing a ~15 % increase 161 
in doubling time compared to the parent strain. The general subtlety of the growth defects was 162 
likely bolstered by the selection of fast-growing colonies at each round of deletion.  163 
CRISPR-Cas3 editing in distinct bacteria 164 
To enable expression of this system in other hosts, we constructed an all-in-one vector 165 
(pCas3cRh) carrying the I-C specific crRNA with a modified repeat sequence and cas3, cas5, 166 
cas8, and cas7 (Supplementary Figure 8A). As a pilot experiment, we transformed wild-type 167 
PAO1 with a non-targeting crRNA and crRNAs targeting phzM and XNES2. Induction of the 168 
targeting crRNAs induced editing efficiencies between 95-100 % (Supplementary Figure 8B-D).  169 
Having verified that pCas3cRh was functional, we tested this system in the model organism 170 
Escherichia coli K-12 MG1655. crRNAs were designed to target lacZ or its vicinity (Figure 4A), 171 
where it is flanked by non-essential DNA (124.5 kb upstream, 22.4 kb downstream). 172 
Transformations were plated directly on inducing media containing X-gal and scored using 173 
blue/white screening. Depending on the crRNA used, directly targeting lacZ or 30 kb upstream 174 
yielded 51-90% or 82-85% editing efficiencies, respectively (Figure 4B). 95 of the 96 LacZ (-) 175 
survivors assayed by PCR showed an absence of the lacZ region. crRNAs downstream of lacZ, 176 
however, had reduced efficiency as they approached the essential gene, hemB. frmA targeting 177 
(13 kb downstream of lacZ) had lower editing efficiencies (21-25 %) and yaiS (18 kb downstream 178 
of lacZ) even lower (2%). This drop in efficiency was independent of the strand being targeted 179 
(and therefore the predicted strand for Cas3 loading and 3’-5’ translocation), confirming the 180 
importance of Cas3 bi-directional deletions. Indeed, WGS of selected lacZ cells revealed bi-181 
directional deletions ranging from 17.5-106 kb encompassing the targeted region (Figure 4C). 182 
Next, we tested Cas3-mediated editing in the plant pathogen Pseudomonas syringae pv. tomato 183 
DC3000, which does not naturally encode a CRISPR-Cas system30. P. syringae encodes many 184 
non-essential virulence effector genes whose activities are difficult to disentangle due to their 185 
redundancy31. We designed crRNAs targeting four chromosomal virulence effector clusters (IV, 186 
VI, VIII, and IX), or one plasmid cluster (pDC300032, cluster X) in P. syringae strain DC3000. Two 187 
clusters (IV and IX) shared identical sequences that could be targeted simultaneously using a 188 
single crRNA. Expression of targeting crRNAs led to a noticeable growth delay compared to non-189 
targeted controls (Figure 4D). PCR analysis of surviving cells showed editing efficiencies of 67-190 
92% (Supplementary Figure 9A). In planta and in vitro growth assays of three deletion mutants 191 
effectively recapitulated the phenotypes of previously described cluster deletion polymutants32 192 
(Figure 4E, Supplementary Figure 9B-G). Targeting cluster X cured the 73 kb plasmid and 193 
simultaneous cluster IV and IX targeting led to dual deletions in 8 out of 12 survivors, with a 194 
sequenced representative having 68.5 kb and 55.3 kb deletions, respectively, at the expected 195 
target sites. The effector cluster VI Cas3-derived mutant had a more severe growth defect in vitro 196 
and in planta than the control mutant (Figure 4E, Supplementary Figure 9B,9E). This large 197 
deletion (100.1 kb in size) likely impacted general fitness (Figure 4F), demonstrating one 198 
drawback of large deletions, but this can be easily overcome by assessing in vitro growth of 199 
multiple isolates. Using our portable minimal system, we achieved three new applications: the 200 
single-step deletion of large virulence regions, multiplexed targeting, and plasmid curing. Overall, 201 
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we have demonstrated I-C CRISPR-Cas3 editing to be a generally applicable tool capable of 202 
generating large genomic deletions in three distinct bacteria. 203 
Repurposing endogenous CRISPR-Cas3 systems for gene editing 204 
Type I CRISPR-Cas3 systems are the most common CRISPR-Cas systems in nature1. Therefore, 205 
many bacteria have a built-in genome editing tool to be harnessed. We first tested the 206 
environmental isolate from which our Type I-C system was derived. Introduction of the self-207 
targeting phzM crRNA led to the isolation of genomic deletions at the targeted site according to 208 
PCR analysis in 0-30% of survivors when wild-type repeats flanked the spacer and 30-60% of 209 
survivors when modified repeats were used (Supplementary Figure 10A). Whole-genome 210 
sequencing of two of these isolates revealed 33.7 (wild-type repeat) and 39 kb (MR) deletions of 211 
the target gene and surrounding regions (Figure 5A). Additionally, HDR-based editing with a 212 
single construct was again efficacious, with 7/10 survivors acquiring the specific 0.17 kb deletion 213 
(Supplementary Figure 10B). Together, these experiments demonstrate the capacity for different 214 
forms of genome editing using a single plasmid and an endogenous CRISPR-Cas system. 215 
We next evaluated the feasibility of repurposing other Type I systems, using the naturally active 216 
Type I-F systems33 encoded by laboratory strain P. aeruginosa PA14, and the clinical strain P. 217 
aeruginosa z8. Plasmids with Type I-F specific crRNAs were expressed, targeting various 218 
genomic sites for deletion (Supplementary Table 3). HDR templates (600 bp arms on average) 219 
were included in the plasmids to generate deletions of defined coordinates ranging from 0.2 to 220 
6.3 kb. Overall, at 5 different genomic target sites in strain z8 and 2 sites in PA14, we observed 221 
desired deletions in 29 - 100 % of analyzed survivor colonies (Figure 5B). This demonstrates a 222 
high recombination efficiency and the feasibility of repurposing other Type I CRISPR-Cas3 223 
systems in the manner we employed for the minimal I-C system. 224 
Finally, one potential impediment to the implementation of any CRISPR-Cas bacterial genome 225 
editing tool is the presence of anti-CRISPR (acr) proteins that inactivate CRISPR-Cas activity34. 226 
In the presence of a prophage expressing AcrIC1 (a Type I-C anti-CRISPR protein26) from a native 227 
acr promoter, self-targeting was completely inhibited, but not by an isogenic prophage expressing 228 
a Cas9 inhibitor AcrIIA435 (Figure 5C). To attempt to overcome this impediment, we expressed 229 
aca1 (anti-CRISPR associated gene 1), a direct negative regulator of acr promoters, from the 230 
same construct as the crRNA. Using this repression-based “anti-anti-CRISPR” strategy, CRISPR-231 
Cas function was re-activated, allowing the isolation of edited cells despite the presence of acrIC1 232 
(Figure 5C and Supplementary Figure 10C). In contrast, simply increasing cas gene and crRNA 233 
expression did not overcome AcrIC1-mediated inhibition (Figure 5C). Therefore, using anti-anti-234 
CRISPRs presents a viable route towards enhanced efficiency of CRISPR-Cas editing and 235 
necessitates continued discovery and characterization of anti-CRISPR proteins and their cognate 236 
repressors. 237 
Discussion 238 
By repurposing a minimal CRISPR-Cas3 system as both an endogenous and heterologous 239 
genome editing tool, we show that hurdles to generating large deletions can be overcome. We 240 
obtained high efficiencies after modifying a repeat sequence to prevent spacer loss. Using only a 241 
single crRNA, we isolated deletions as large as 424 kb without requiring the insertion of a 242 
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selectable marker or HDR templates guiding the repair process. Additionally, the I-C system 243 
appears to produce bi-directional deletions, similar to what was previously observed with the I-F 244 
CRISPR-Cas3 system36,37, but not with type I-E9,10,22. CRISPR-Cas3 presents a genome editing 245 
tool useful for the targeted removal of large elements (e.g. virulence clusters, plasmids) and also 246 
for unbiased screening and genome streamlining. As a long-term goal of microbial gene editing 247 
has been genome minimization38,39,57, we used our optimized CRISPR-Cas3 system to generate 248 
ten iterative deletions, achieving >13 % genome reduction of the targeted strain. This spanned 249 
only 30 days while maintaining editing efficiency, a great improvement over previous genome 250 
reduction methods40. Some basic microbial applications of Cas3 include studying chromosome 251 
biology (e.g. replichore asymmetry41), virulence factors42, and the impact of the mobilome.  252 
An important outcome of this work is the enhanced recombination observed at cut sites when 253 
comparing Cas3 and Cas9 directly. The potential for Cas3 to be more recombinogenic through 254 
the generation of exposed ssDNA may be advantageous for both programmed knock-outs and 255 
for programmed knock-ins. The direct comparison between Cas3 (large deletions) and Cas9 256 
(small deletions) presented here confirms the causality of Cas3 in the deletion outcomes.  257 
Our study has revealed some of the benefits and challenges of working with CRISPR-Cas3. While 258 
some of the iteratively edited strains demonstrated slight growth defects, the Cas3 editing 259 
workflow shows high potential for genome minimization efforts. Since many distinct deletion 260 
events are generated, screening various isolates for fitness benefits or defects is possible, and 261 
one can proceed with the strain that has the desired fitness property. Additionally, if the location 262 
of essential genes within an organism’s genome is not fully described, this is not an impediment 263 
as editing efficiency drops precipitously when targeting near essential genes. Finally, despite our 264 
success at transplanting the minimal Type I-C system, it remains to be seen whether the approach 265 
will be limited by differences in DNA repair mechanisms. Indeed, in E. coli and P. syringae, larger 266 
regions of homology, such as 34 bp long REP sequences were observed, indicating the role of 267 
RecA-mediated homologous recombination43 in the repair process. Meanwhile in P. aeruginosa, 268 
the borders of the deletions showed either small (4-14 bp) micro-homologies or no noticeable 269 
sequence homology. The former implies a role for alternative end-joining29, while the latter non-270 
homologous end-joining44 in the repair process. Downstream studies are required to dissect the 271 
roles of each mechanism in the deletion generation process for better predictable deletion 272 
outcomes.  273 
CRISPR-Cas3 is an especially promising tool for use in eukaryotic cells as it would facilitate the 274 
interrogation of large segments of non-coding DNA, much of which has unknown function45. 275 
Additionally, it was recently shown that Cas9-generated “gene knockouts” (i.e. small indels 276 
causing out-of-frame mutations) frequently encode pseudo-mRNAs that may produce protein 277 
products, necessitating methods for full gene removal46,47. Encouragingly, a Type I-E CRISPR-278 
Cas system was recently delivered to human cells as a ribonucleoprotein (RNP) complex and 279 
resulted in large deletions22, demonstrating the feasibility of Cas3-mediated editing in human 280 
cells. Overall, the intrinsic properties of Cas3 make it a promising tool to fill a void in current gene 281 
editing capabilities. Employing Cas3 to make large genomic deletions will facilitate the 282 
manipulation of repetitive and non-coding regions, having a broad impact on genetics research 283 
by providing a tool to probe genomes en masse, as well as the capability to rapidly streamline 284 
genomes for synthetic biology. 285 
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  286 
Methods 287 
Bacterial strains, plasmids, DNA oligonucleotides, and media 288 
A previously described26 environmental strain of Pseudomonas aeruginosa was used as a 289 
template to amplify the four cas genes of the Type I-C CRISPR-Cas system genes (cas3, cas5, 290 
cas7, and cas8). The genes were cloned into the pUC18-mini-Tn7T-LAC vector48 using the SacI-291 
PstI restriction endonuclease cut sites in the order cas5, cas7, cas8, cas3 to generate the plasmid 292 
pJW31 (Addgene number: 136423). This vector was introduced into Pseudomonas aeruginosa 293 
PAO149, inserting the cas genes into the chromosome, following previously described methods50. 294 
Following integration, the excess sequences, including the antibiotic resistance marker, were 295 
removed via Flp-mediated excision as described previously50. The resulting strain, dubbed 296 
PAO1IC, allowed for inducible expression of the I-C system through induction with isopropyl -D-297 
1 thiogalactopyranoside (IPTG). An isogenic strain carrying Cas9 derived from Streptococcus 298 
pyogenes was constructed in the same fashion, resulting in the strain PAO1IIA. For experiments 299 
to test the system in Pseudomonas syringae, we employed the previously characterized strain 300 
DC300030. E. coli editing experiments were conducted with strain K-12 MG165551.  301 
To achieve genomic self-targeting of the I-C CRISPR-Cas strains, crRNAs designed to target the 302 
genome were expressed from the pHERD20T and pHERD30T shuttle vectors52. So-called “entry 303 
vectors” pHERD20T-ICcr and pHERD30T-ICcr were first generated by cloning at the EcoRI and 304 
HindIII sites an annealed linear dsDNA template carrying the I-C CRISPR-Cas system repeat 305 
sequences flanking two BsaI Type IIS restriction endonuclease recognition sites. Additionally, a 306 
preexisting BsaI site in a non-coding site of the pHERD30T and pHERD20T plasmids was 307 
mutated using whole-plasmid amplification so it would not interfere with the cloning of the 308 
crRNAs26. Oligonucleotides with repeat-specific overhangs encoding the various spacer 309 
sequences were annealed and phosphorylated using T4 polynucleotide kinase (PNK) and cloned 310 
into the entry vectors using the BsaI sites. For experiments using Cas9, sgRNAs were expressed 311 
from the same pHERD30T vector, with the sgRNA construct cloned using the same restriction 312 
sites as with the I-C crRNAs.   313 
The all-in-one vector pCas3cRh (Addgene number 133773) is a derivative of the pHERD30T-IC 314 
plasmid, with the 4 I-C system genes cloned downstream of the crRNA site. This was achieved 315 
by amplifying the genes cas3, cas5, cas8, and cas7 in two fragments with a junction within cas8 316 
designed to eliminate an intrinsic BsaI site with a synonymous point mutation. The amplified 317 
fragments were cloned into pHERD30T-IC using the Gibson assembly protocol53. Finally, to guard 318 
against potential leaky toxic expression, we replaced the araC-ParaBAD promoter with the 319 
rhamnose-inducible rhaSR-PrhaBAD system54. The sequence for rhaSR-PrhaBAD was amplified 320 
from the pJM230 template54, provided by the lab of Joanna B. Goldberg (Emory University), and 321 
cloned into the pHERD30T-IC plasmid to replace araC-ParaBAD using Gibson Assembly (New 322 
England Biolabs). Without induction, transformation efficiencies of targeting constructs of 323 
assembled pCas3cRh were on average 5-10-fold lower when compared to non-targeting controls 324 
(Supplementary Figure 8C), indicating residual leakiness of the I-C system.  325 
The aca1-containing vector pICcr-aca1 is a derivative of the pHERD30T-ICcr plasmid, with aca1 326 
cloned downstream of the crRNA site under the control of the pBAD promoter. The aca1 gene 327 
was cloned from P. aeruginosa phage DMS3m.  328 
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All oligonucleotides used in this study were obtained from Integrated DNA Technologies. For a 329 
complete list of all DNA oligonucleotides and a short description, see Supplementary Table 4. 330 
P. aeruginosa and E. coli strains were grown in standard Lysogeny Broth (LB): 10 g tryptone, 5 g 331 
yeast extract, and 10 g NaCl per 1 L dH2O. Solid plates were supplemented with 1.5 % agar. P. 332 
syringae was grown in King’s medium B (KB): 20 g Bacto Proteose Peptone No. 3, 1.5 g K2HPO4, 333 
1.5 g MgSO4•7H2O, 10 ml glycerol per 1 L dH2O, supplemented with 100 g/ml rifampicin. The 334 
following antibiotic concentrations were used for selection: 50 g/ml gentamicin for P. aeruginosa 335 
and P. syringae, 15 g/ml for E. coli; 50 g/ml carbenicillin for all organisms. Inducer 336 
concentrations were 0.5 mM IPTG, 0.1 % arabinose, and 0.1 % rhamnose. For transformation 337 
protocols, all bacteria were recovered in Super optimal broth with catabolite repression (SOC): 20 338 
g tryptone, 5 g yeast extract, 10mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM, MgSO4, and 20 339 
mM glucose in 1 L dH2O. 340 
 341 
Bacterial transformations 342 
Transformations of P. aeruginosa, E. coli, and P. syringae strains were conducted using standard 343 
electroporation protocols. 10 ml of overnight cultures were centrifuged and washed twice in an 344 
equal volume of 300 mM sucrose (20 % glycerol for E. coli) and suspended in 1 ml 300 mM 345 
sucrose (20 % glycerol for E. coli). 100 l aliquots of the resulting competent cells were 346 
electroporated using a Gene Pulser Xcell Electroporation System (Bio-Rad) with 50 – 200 ng 347 
plasmid with the following settings: 200 , 25 F, 1.8 kV, using 0.2 mm gap width electroporation 348 
cuvettes (Bio-Rad). Electroporated cells were incubated in antibiotic-free SOC media for 1 hour 349 
at 37 °C (28 °C for P. syringae), then plated onto LB agar (KB agar for P. syringae) with the 350 
selecting antibiotic, and grown overnight at 37 °C (28 °C for P. syringae). Cloning procedures 351 
were performed in commercial E. coli DH5 cells (New England Biolabs) or E. coli XL1-Blue (QB3 352 
Macrolab Berkeley), according to the manufacturer’s protocols.  353 
 354 
Construction of recombinant DMS3m acr phages 355 
The isogenic DMS3m acrIIA4 and acrIC1 phages were constructed using previously described 356 
methods55. A recombination cassette, pJZ01, was constructed with homology to the DMS3m acr 357 
locus. Using Gibson Assembly (New England Biolabs), either acrIC1 or acrIIA4 were cloned 358 
upstream of aca1, and the resulting vectors were used to transform PAO1IC. The transformed 359 
strains were infected with WT DMS3m, and recombinant phages were screened for. Phages were 360 
stored in SM buffer at 4 °C. 361 
 362 
Isolation of PAO1IC lysogens 363 
PAO1IC was grown overnight at 37 °C in LB media. 150 l of overnight culture was added to 4 ml 364 
of 0.7 % LB top agar and spread on 1.5 % LB agar plates supplemented with 10 mM MgSO4.  5 365 
l of phage, expressing either acrIC1 or acrIIA4 were spotted on the solidified top agar and plates 366 
were incubated at 30 °C overnight. Following incubation, bacterial growth within the plaque was 367 
isolated and spread on 1.5 % LB agar plate. After an overnight incubation at 37 °C, single colonies 368 
were assayed for the prophage. Confirmed lysogens were used for genomic targeting 369 
experiments.  370 
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 371 
Genomic targeting 372 
Pseudomonas aeruginosa 373 
Genomic self-targeting of P. aeruginosa PAO1IC was achieved by electroporating cells with 374 
pHERD30T (or pHERD20T) expressing the self-targeting spacer of choice. Cells were plated onto 375 
LB agar plates containing the selective antibiotic, without inducers, and grown overnight. Single 376 
colonies were then grown in liquid LB media containing the selective antibiotic, as well as IPTG 377 
to induce the genomic expression of the I-C system genes, and arabinose to induce the 378 
expression of the crRNA from the plasmid. The aca1-containing crRNA plasmids do not need 379 
additional inducers, as the pBAD promoter controls aca1. Cultures were grown at 37 °C in a 380 
shaking incubator overnight to saturation, then plated onto LB agar plates containing the selecting 381 
antibiotic, as well as the inducers, and incubated overnight again at 37 °C. The resulting colonies 382 
were then analyzed individually using colony PCR for any differences at the targeted genomic 383 
site compared to a wild-type cell. gDNA was isolated by resuspending 1 colony in 20 l of H2O, 384 
followed by incubation at 95 °C for 15 min. 1-2 l of boiled sample was used for PCR. The primers 385 
used to assay the targeted sites were designed to amplify genomic regions 1.5 - 3 kb in size. In 386 
the event of a PCR product equal to or smaller than the wild-type fragment (as was often observed 387 
when analyzing Cas9-targeted cells), Sanger sequencing (Quintara Biosciences) was used to 388 
determine any modifications of the targeted sequences. In some cases, additional analysis of the 389 
crRNA-expressing plasmids of the surviving colonies was also performed, by isolating and 390 
reintroducing the plasmids into the original I-C CRISPR-Cas strain, where functional self-targeting 391 
could be determined based on a significant increase in the lag time of induced cultures, 392 
characteristic of self-targeting events.  393 
Escherichia coli 394 
Genomic self-targeting of E. coli was conducted in a similar fashion as P. aeruginosa, except 395 
using the pCas3cRh all-in-one vector. Electrocompetent E. coli cells were transformed with 396 
pCas3cRh expressing a crRNA targeting the genome. Individual transformants were selected and 397 
grown in liquid LB media containing the selecting antibiotic (gentamicin) overnight without any 398 
inducers added. The overnight cultures were then plated in the presence of inducer and X-gal to 399 
screen for functional lacZ (LB agar + 15 g/ml gentamicin + 0.1 % rhamnose + 1 mM IPTG + 20 400 
g/ml X-gal) and blue/white colonies were counted the next day. 401 
Pseudomonas syringae 402 
Electrocompetent P. syringae cells were also transformed with pCas3cRh plasmids targeting 403 
selected genomic sequences. Initial transformants were plated onto KB agar + 100 g/ml 404 
rifampicin + 50 g/ml gentamicin plates, and incubated at 28 °C overnight. Single colony 405 
transformants were then selected and inoculated in KB liquid media supplemented with rifampicin, 406 
gentamicin, and 0.1 % rhamnose inducer, and grown to saturation in a shaking incubator at 28 407 
°C. Cultures were finally plated onto KB agar plates with rifampicin, gentamicin, and rhamnose 408 
and incubated at 28 °C. Individual colonies were finally assayed with colony PCR to determine 409 
the presence of deletions at the targeted genomic sites. 410 
 411 
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Iterative genome minimization 412 
Iterative targeting to generate multiple deletions in the P. aeruginosa PAO1IC strain was carried 413 
out by alternating the pHERD30T and pHERD20T plasmids each expressing different crRNAs 414 
targeting the genome. Each crRNA designed to target the genome was cloned into both the 415 
pHERD30T plasmid, which confers gentamicin resistance, as well as the pHERD20T plasmid, 416 
which confers carbenicillin resistance. After first transforming and targeting with a pHERD30T 417 
plasmid expressing a specific crRNA, deletion candidate isolates were transformed with a 418 
pHERD20T expressing a crRNA targeting a different genomic region. As the two plasmids are 419 
identical with the exception of the resistance marker, this eliminated the necessity for curing of 420 
the original plasmid to be able to target a different region. For the next targeting event, the 421 
pHERD30T plasmid could again be used, this time expressing another crRNA targeting a different 422 
genomic region. In this manner, pHERD30T and pHERD20T could be alternated to achieve 423 
multiple deletions in a rapid process. At each new transformation step, the cells were checked for 424 
any residual resistance to the given antibiotic from a previous cycle. Additionally, functionality of 425 
the CRISPR-Cas system of the edited cells could be determined through the introduction of a 426 
plasmid expressing crRNA targeting the D3 bacteriophage34, then performing a phage spotting 427 
assay to see if phage targeting was occurring or not. 428 
 429 
Measurement of growth rates 430 
Pseudomonas aeruginosa 431 
Growth dynamics of various strains were measured using a Synergy 2 automated 96-well plate 432 
reader (Biotek Instruments) and the accompanying Gen5 software (Biotek Instruments). 433 
Individual colonies were picked and grown overnight in 300 l volumes of LB in 96-well deep-well 434 
plates at 37 °C. The grown cultures were then diluted 100-fold into 100 l of fresh LB in a 96-well 435 
clear microtitre plate (Costar) and sealed with Microplate sealing adhesive (Thermo Scientific). 436 
Small holes were punched in the sealing adhesive for each well for increased aeration. Doubling 437 
times were calculated as described previously56.  438 
Pseudomonas syringae 439 
To test bacterial growth in planta, we used the Arabidopsis thaliana ecotype Columbia (Col-0), 440 
which has previously been shown to be susceptible to infection by P. syringae DC3000. Plants 441 
were grown for 5-6 weeks in 9h light/15h darkness and 65 % humidity. For each inoculum, we 442 
measured bacterial growth in 10 individual Col-0 plants. Four leaves from each plant were 443 
infiltrated at OD600 = 0.0002, and cored with a #3 borer. The four cores from each plant were then 444 
ground, resuspended in 10 mM MgCl2 and plated in a dilution series on selective media for colony 445 
counts at both the time of infection and 3 days post-infection.  446 
To test bacterial growth in vitro, we used both KB and plant apoplast mimicking minimal media 447 
(MM)57. Overnight cultures were prepared from single colonies of each strain, washed, and diluted 448 
to OD600 = 0.1 in 96-well plates using either KB or MM. Plates were incubated with shaking at 28 449 
°C. OD600 was measured over the course of 24-25 hours using an Infinate 200 Pro automated 450 
plate reader (Tecan). Statistical analysis determined significantly different groups based on 451 
ANOVA analysis on the day 0 group of values and the day 3 group of values. Significant ANOVA 452 
results (p<0.01) were further analyzed with a Tukey’s HSD post hoc test to generate adjusted p-453 
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values for each pairwise comparison. A significance threshold of 0.01 was used to determine 454 
which treatment groups were significantly different. 455 
 456 
Bacteriophage plaque (spot) assays 457 
Bacteriophage plaque assays were performed using 1.5 % LB agar plates supplemented with 10 458 
mM MgSO4 and the appropriate antibiotic (gentamicin or carbenicillin, depending on the plasmid 459 
used to express the crRNA), and 0.7 % LB top agar supplemented with 0.5 mM IPTG and 0.1 % 460 
arabinose inducers added covering the whole plate. 150 l of the appropriate overnight cultures 461 
was suspended in 4 ml molten top agar poured onto an LB agar plate leading to the growth of a 462 
bacterial lawn. After 10-15 minutes at room temperature, 3 l of ten-fold serial dilutions of 463 
bacteriophage was spotted onto the solidified top agar. Plates were incubated overnight at 30 °C 464 
and imaged the following day using a Gel Doc EZ Gel Documentation System (BioRad) and Image 465 
Lab (BioRad) software. The following bacteriophage were used in this study: bacteriophage 466 
JBD3034, bacteriophage D358, and bacteriophage DMS3m59.  467 
  468 
Whole-genome sequencing 469 
Genomic DNA for whole-genome sequencing (WGS) analysis was isolated directly from bacterial 470 
colonies using the Nextera DNA Flex Microbial Colony Extraction kit (Illumina) according to the 471 
manufacturer’s protocol. Genomic DNA concentration of the samples was determined using a 472 
DS-11 Series Spectrophotometer/Fluorometer (DeNovix) and all fell into the range of 200-500 473 
ng/l. Library preparation for WGS analysis was done using the Nextera DNA Flex Library Prep 474 
kit (Illumina) according to the manufacturer’s protocol starting from the tagment genomic DNA 475 
step. Tagmented DNA was amplified using Nextera DNA CD Indexes (Illumina). Samples were 476 
placed overnight at 4 °C following the tagmented DNA amplification step, then continued the next 477 
day with the library clean up steps. Quality control of the pooled libraries was performed using a 478 
2100 Bioanalyzer Instrument (Agilent Technologies) with a High Sensitivity DNA Kit (Agilent 479 
Technologies). The majority of samples were sequenced using a MiSeq Reagent Kit v2 (Illumina) 480 
for a 150 bp paired-end sequencing run using the MiSeq sequencer (Illumina). P. syringae and 481 
Cas9-generated P. aeruginosa deletion strains were sequenced using a NextSeq 500 Reagent 482 
Kit v2 (Illumina) for a 150 bp paired-end sequencing run using the NextSeq 500 sequencer 483 
(Illumina). 484 
Genome sequence assembly was performed using Geneious Prime software version 2019.1.3. 485 
Paired read data sets were trimmed using the BBDuk (Decontamination Using Kmers) plugin 486 
using a minimum Q value of 20. The genome for the ancestral PAO1IC strain was de novo 487 
assembled using the default automated sensitivity settings offered by the software. The 488 
consensus sequence of PAO1IC assembled in this manner was then used as the reference 489 
sequence for mapping all of the PAO1IC strains with multiple deletions. As a control, the 490 
sequences were also mapped to the reference P. aeruginosa PAO1 sequence (NC_002516) to 491 
verify deletion border coordinates. Coverage of these sequenced strains ranged from 66 to 143-492 
fold, with an average of 98.3-fold. The sequenced P. aeruginosa environmental strains were also 493 
mapped to the PAO1 (NC_002516) reference, while the sequenced E. coli strains were mapped 494 
to the E. coli K-12 MG1655 reference sequence (NC_000913). Finally, sequenced P. syringae 495 
strains were mapped to the P. syringae DC3000 (NC_004578) reference sequence, along with 496 
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the pDC3000A endogenous 73.5 kb plasmid sequence (NC_004633). All of the remaining 497 
sequenced strains had > 100-fold coverage. All deletion junction sequences were manually 498 
verified by the presence of multiple reads spanning the deletions, containing sequences from both 499 
end boundaries.  500 
WGS data was visualized using the BLAST Ring Image Generator (BRIG) tool60 employing 501 
BLAST+ version 2.9.0. In several cases, short sequences were aligned within previously 502 
determined large deletions at redundant sequences such as transposase genes. Such 503 
misrepresentations created by BRIG were manually removed to reflect the actual sequencing 504 
data.   505 
Data availability 506 
Raw whole-genome sequencing data associated with Figures 1D, 3B, 4A, 4C, 4F, and 5A) has 507 
been uploaded to GenBank (Submission number SUB6598604, accession number pending) and 508 
is also available, along with bacterial strains, upon request from the corresponding author. 509 
Correspondence and requests for strains should be addressed to J.B.D. (joseph.bondy-510 
denomy@ucsf.edu). Pseudomonas aeruginosa strains available for laboratories with BSL-2 511 
clearance.  512 
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Figure 1. A) A schematic of the Type I-C cas gene operon and CRISPR array. The surveillance 537 
complex is made up of Cas proteins (Cas51:Cas81:Cas77) and one crRNA, which recruits Cas3 538 
upon target DNA recognition. B) Growth curves of 2 PAO1IC strains expressing different crRNAs 539 
targeting phzM (green and orange) compared to a non-targeting strain (blue). Values are the 540 
mean of 8 biological replicates each, error bars indicate SD values. C) Cultures resulting from 541 
phzM targeting, in the absence of inducer (-ind), presence (+ind), and after recovery. D) Whole-542 
genome sequencing of three PAO1IC self-targeted survivor strains. Bars indicate boundaries of 543 
deletions; red arrow indicates genomic position of targeted sequences.  544 
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Figure 2. A) Percentage of survivors with a genomic deletion at the location targeted. Six different 548 
crRNA constructs with either wild-type (Wt) repeat sequences (light green) or with the second 549 
repeat being modified (dark green). Values are means of 3 biological replicates each, where 12 550 
individual surviving colonies were assayed per replicate, error bars show SD values. B) Sequence 551 
and structure of natural and modified repeat sequences. Specifically engineered modified 552 
nucleotides shown in red; repeat sequences highlighted in gray with an arbitrary intervening 553 
spacer sequence. C) Growth curves of PAO1IC strains expressing distinct self-targeting crRNAs 554 
flanked by modified repeats. Non-targeting crRNA expressing control is marked in blue. Values 555 
depicted are averages of 4 biological replicates each. D) Gene editing outcomes for distinct 556 
survivor cells targeted with either a Type II-A SpyCas9 system or a Type I-C Cas3 system (n=72). 557 
E) Percentage of survivors with the specific deletion size present (0.17 kb, 56.5 kb, or 249 kb) 558 
using homologous repair templates with the Cas3 system (green) or the SpyCas9 system (blue). 559 
Values are means of 3 biological replicates each, where 12 individual surviving colonies were 560 
assayed per replicate, error bars show SD values, ND: not detected.     561 
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Figure 3. A) Schematic overview of the iterative deletion generating process.  B) Whole-genome 565 
sequences of six PAO1IC strains that have been iteratively targeted at six distinct genomic 566 
positions and one (derived from strain ∆66) with ten total deletions (∆10) aligned to the parental 567 
P. aeruginosa PAO1IC strain. The first six targeted sites are marked with red arrows, and the final 568 
four are marked with blue arrows. C) Calculated doubling times of the seven genome-reduced 569 
strains (strains ∆61 – 66 with six deletions, ∆10 with ten) compared to the parent PAO1IC strain 570 
(green). Values are means of 8 biological replicates, error bars represent SD values, * p < 0.05, 571 
** p < 0.01, paired T-test compared to PAO1IC. 572 
   573 
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Figure 4. A) Schematic of the crRNA targeted sites in the E. coli MG1655 genome at the lacZ 577 
locus. B) lacZ deletion efficiencies using distinct crRNAs targeting the E. coil K-12 MG1655 578 
chromosome. Efficiencies calculated based on LacZ activity. Values are averages of 3 biological 579 
replicates, error bars represent standard deviations. C) Whole-genome sequencing of an E. coli 580 
deletion mutant targeted 30 kb upstream of lacZ at pdeL. D) Growth of P. syringae DC3000 strains 581 
expressing the I-C system and distinct crRNAs. Constructs VI, IV-IX, and VIII target P. syringae 582 
DC3000 non-essential chromosomal genes, non-targeting crRNA (NT), empty vector (EV). E) 583 
Bacterial growth of deletion mutants in Arabidopsis thaliana. Values are differences in colony 584 
forming units (cfu) / ml counted on day 0 of the experiment and day 3, shown on a logarithmic 585 
scale. The wild-type DC3000 strain is shown in black, while gray bars represent previously 586 
constructed polymutant control (C) strains of the different clusters (labeled at bottom), and 587 
green and blue bars show deletion mutants generated using Cas3 (two isolated strains for 588 
each targeted cluster, #1, #2). Values shown are means of 10 biological replicates each (30 589 
for DC3000), error bars show SD values, ** p < 0.01, *** p < 0.005, ANOVA analysis (see 590 
methods). F) Whole-genome sequencing of P. syringae deletion mutants. Left panel shows 591 
virulence cluster VI targeting, while right panel shows virulence cluster IV and IX targeting with a 592 
single crRNA, as the clusters share sequence identity. 593 
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Figure 5. A) Schematic of whole genome sequencing of an environmental isolate of PAO1 with 597 
an endogenous Type I-C system. Two survivors were isolated post-targeting using either WT 598 
direct repeats flanking the spacer, or modified repeats. B) Editing efficiencies at targeted genomic 599 
sites using homologous templates in a laboratory (PA14) and clinical (z8) strain of P. aeruginosa. 600 
See Supplementary Table 3 for additional details. C) Growth curves of PAO1IC lysogenized by 601 
recombinant DMS3m phage expressing acrIIA4 or acrIC1 from the native acr locus. CRISPR-602 
Cas3 activity is induced with either 0.5mM (+) or 5mM (++) IPTG and 0.1% (+) or 0.3% (++) 603 
arabinose. Edited survivors reflect number of isolated survivor colonies missing the targeted gene 604 
(phzM). Each growth curve is the average of 10 biological replicates and error bars represent SD.   605 
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Supplementary Figure 1. PCR amplification of a 3 kb genomic fragment flanking the phzM gene 608 
targeted using two different crRNAs, phzM_1 and phzM_2. Colony PCRs were performed on 18 609 
biological replicates of self-targeted strains for each crRNA. The PAO1IC parental strain is used 610 
as a positive control (wt). L indicates a 1 kb DNA ladder.  611 
  612 
.CC-BY-NC 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.




Supplementary Figure 2. A) Phage targeting assays with survivors that had no discernable 615 
deletion of the crRNA-targeted genomic site. Strains were transformed with a D3 phage-targeting 616 
crRNA to assay for IC CRISPR-Cas3 activity. Three unique survivors were isolated from six self-617 
targeting assays for a total of 18 survivors. Control is a non-targeting crRNA. B) Schematic of 618 
spacer excision events where the two direct repeats recombine, resulting the loss of the targeting 619 
spacer. C) PCR amplification of the crRNA sequence from plasmids isolated from 17 non-deletion 620 
self-targeted survivors. Pl indicates the original plasmid as the PCR template, Ni indicates a 621 
sample where the crRNA was not induced, L indicates a 1 kb DNA ladder.   622 
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Supplementary Figure 3. A) Phage-targeting assay showing the activity of the modified repeat 626 
crRNA constructs. Ten-fold serial dilutions of DMS3 phage and D3 phage were spotted on lawns 627 
of PAO1IC expressing either empty vector (top), a crRNA targeting D3 with WT direct repeats 628 
(middle), or a crRNA targeting D3 with modified repeats (bottom).  B) Phage targeting assay of 629 
five non-deletion self-targeting survivors expressing a D3 phage targeting crRNA. Unsuccessful 630 
targeting of phage indicates a non-functional CRISPR-Cas system in these strains. The parental 631 
PAO1IC strain with a functional CRISPR-Cas system was used as a control.   632 
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 633 
Supplementary Figure 4. A) Growth curves of 36 PAO1IC biological replicates targeting the 634 
essential gene, rplQ, using the MR crRNA plasmid. B) Phage targeting assays with eight isolated 635 
rplQ-targeted survivors to assay for I-C CRISPR-Cas activity. Serial dilutions of DMS3 phage and 636 
D3 phage were spotted on lawns of PAO1IC expressing a crRNA targeting phage D3. The parent 637 
PAO1IC strain expressing a D3 targeting crRNA (top left) was used as a positive control, while 638 
PAO1IC expressing a non-targeting crRNA was used as a negative control.  639 
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Supplementary Figure 5. Growth of self-targeting strains of PAO1IIA expressing a self-targeting 643 
crRNA targeting the genome at phzM (Ind.). An empty vector (E.V.) and a non-induced phzM 644 
targeting strain (N.I.) were used as controls. Mean OD values measured at 600 nm are shown for 645 
8 biological replicates each, error bars indicate SD values.  646 
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Supplementary Figure 6. Schematic overview of the generation of deletions with predetermined 650 
coordinates of various sizes. Sequences with ~400 bp homology to genomic sites (purple and 651 
yellow boxes for the short deletion, red and orange boxes for the long deletion) were cloned into 652 
the vector crRNA vector.  653 
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Supplementary Figure 7. Deletion efficiencies observed over six cycles of iterative self-targeting. 657 
Six genomic targets were targeted in six different orders. Six survivors were analyzed using site-658 
specific PCR after each cycle, for a total of 36 analyzed colonies (6*6) after each cycle.  659 
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Supplementary Figure 8. A) Map of the I-C CRISPR-Cas all-in-one plasmid pCas3cRh carrying 663 
I-C crRNA and genes cas3, cas5, cas8, and cas7 under the control of the rhamnose-inducible 664 
rhaSR-PrhaBAD system. B) Growth curve of PAO1 transformed with the pCas3cRh vector 665 
expressing a self-targeting crRNA targeting phzM (Ind.). An empty vector (E.V.) and a non-666 
induced phzM targeting strain (N.I.) were used as controls. Mean OD values measured at 600 nm 667 
are shown for six biological replicates each.  C) Deletion efficiencies for WT PAO1 using the all-668 
in-one vector pCas3cRh carrying all necessary components of the I-C CRISPR-Cas system. 669 
Values are averages of three replicates where 12 individual colonies were analyzed using site-670 
specific PCR. Error bars show standard deviations. D) Transformation efficiencies with self-671 
targeting pCas3cRh vectors expressing crRNAs for phzM or XNES 2 compared to a non-targeting 672 
control (green bar) in PAO1. Values are means of 3 replicates each, error bars represent SD 673 
values. 674 
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Supplementary Figure 9. A) Percentage of survivors with targeted deletions in clusters of non-678 
essential virulence effector genes in P. syringae pv. tomato DC3000. Values are averages of 679 
three biological replicates where 12 individual colonies were analyzed using site-specific PCR for 680 
each, error bars show standard deviations. B) In vitro growth of cluster VI deletion strains in King’s 681 
medium B (KB). CEL is the previously published polymutant, while CVI-1 and CVI-2 are Cas3-682 
generated mutants. Error bars represent standard deviation, n = 4. C) In vitro growth of cluster 683 
IV, cluster IX deletion strains in KB. CEL is the previously published polymutant, while 684 
CIVCIX-1 and CIVCIX-2 are Cas3-generated mutants. Error bars represent standard 685 
deviation, n = 4. D) In vitro growth of cluster X deletion strains in KB. CEL is the previously 686 
published polymutant, while CX-1 and CX-2 are Cas3-generated mutants. Error bars represent 687 
standard deviation, n = 4. E) In vitro growth of cluster VI deletion strains in apoplast mimicking 688 
minimal media (MM). CEL is the previously published polymutant, while CVI-1 and CVI-2 are 689 
Cas3-generated mutants. Error bars represent standard deviation, n = 4. F) In vitro growth of 690 
cluster IV, cluster IX deletion strains in MM. CEL is the previously published polymutant, while 691 
CIVCIX-1 and CIVCIX-2 are Cas3-generated mutants. Error bars represent standard 692 
deviation, n = 4. G) In vitro growth of cluster X deletion strains in MM. CEL is the previously 693 
published polymutant, while CX-1 and CX-2 are Cas3-generated mutants. Error bars represent 694 
standard deviation, n = 4. 695 
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Supplementary Figure 10. A) Editing efficiencies for the Pseudomonas aeruginosa 700 
environmental isolate naturally expressing the Type I-C cas genes, transformed with a plasmid 701 
targeting phzM with WT repeats or modified repeats. Each data point represents the fraction of 702 
isolates with the deletion out of ten isolates assayed.  B) Genotyping results for the Pseudomonas 703 
aeruginosa environmental isolate using the 0.17 kb HDR template. Larger band corresponds to 704 
the WT sequence, smaller band corresponds to a genome reduced by 0.17 kb. C) Genotyping 705 
results of PAO1IC AcrC1 lysogens after self-targeting induction in the presence or absence of 706 
aca1 and a non-targeted control. Ten biological replicates per strain were assayed. gDNA was 707 
extracted from each replicate and PCR analysis for the phzM gene (targeted gene, top row of 708 
gels) or cas5 gene (non-targeted gene, bottom row) was conducted. Only cells that co-expressed 709 
aca1 with the crRNA showed loss of the phzM band, indicating genome editing. All replicates had 710 
a cas5 band, indicating successful gDNA extraction and target specificity for the phzM locus. 711 
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Region Coordinates Size 
XNES 1 27535 – 142359 114 kb 
XNES 2 143267 – 371151  228 kb 
XNES 3 491900 – 606160 114 kb 
XNES 4 841825 – 986817 145 kb 
XNES 5 1147815  – 1249907  102 kb 
XNES 6 1260442  – 1491913  232 kb 
XNES 7 1974210 – 2150828  176 kb 
XNES 8 2216121  – 2375804  160 kb 
XNES 9 2376541  – 2923367  546 kb 
XNES 10 2972700  – 3079197  106 kb 
XNES 11 3155072  – 3309411  154 kb 
XNES 12 3587303  – 3802567  216 kb 
XNES 13 3897357  – 4062426  165 kb 
XNES 14 4294208 – 4457362  163 kb 
XNES 15 4576324 – 4753990  178 kb 
XNES 16 6025305  – 6180942  156 kb 
 713 
 714 
Supplementary Table 1. Extended, non-essential regions (XNES) of P. aeruginosa PAO1 715 
genome with contiguous, individually non-essential genes in a complex laboratory medium 716 
exceeding 100 kb. Data based on a transposon sequencing dataset from Turner et al.27. 717 
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Supplementary Table 2. Genomic coordinates and extent of homologous sequences at genomic 719 
deletion junctions of whole-genome sequenced self-targeting strains of P. aeruginosa, P. 720 
syringae, and E. coli. See separate Excel File. 721 
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HR template length (left + 
right, bp) 
PA14 psiF 100 0 0 12 0.5 600 + 600 
PA14 rebB 50 50 0 16 4.1 600 + 600 
z8 ghlO 100 0 0 5 0.2 600 + 600 
z8 mexZ 75 25 0 12 0.6 722 + 600 
z8 psiF 100 0 0 12 0.5 600 + 600 
z8 qsrO 29(80)* 71 0 14 0.4 751 + 596 
z8 teg 75 25 0 4 6.3 800 + 809 
 723 
Supplementary Table 3. Summary of HR-mediated genome editing experiments using the Type 724 
I-F CRISPR-Cas3 system. Genes were targeted for deletion in the strains PA14 and z8. 725 
Experiments targeted 4 single genes and 2 gene blocks, teg and rebB, that comprise X and Y 726 
genes, respectively. Transformants were classified as 1) ‘HR edits’ that have the HR designed 727 
deletion; 2) ‘non-templated edits’ that have a non-designed deletion encompassing the targeted 728 
gene, 3) ‘no edits’ where the targeted gene is intact. (*) two colony morphologies with different 729 
editing frequencies were obtained in this experiment. 730 
731 
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Supplementary Table 4. List of oligonucleotides (including crRNA sequences) used in the study. 732 
See separate Excel File. 733 
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